Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
Objective: To study the impact of multiphase quality improvement efforts to enhance appropriate use of chemical and mechanical venous thromboembolism (VTE) prophylaxis (VTEP) on the rate of hospital-acquired VTE and determine whether efforts have been associated with increased bleeding complications...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454819301560 |
id |
doaj-1b3dd7e3519045c191382ebba50e725b |
---|---|
record_format |
Article |
spelling |
doaj-1b3dd7e3519045c191382ebba50e725b2020-11-25T03:24:54ZengElsevierMayo Clinic Proceedings: Innovations, Quality & Outcomes2542-45482020-04-0142159169Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism ProphylaxisJenna K. Lovely, PharmD, RPh, BCPS0Joel A. Hickman, BS1Matthew G. Johnson, MPH2James M. Naessens, ScD, MPH3Timothy I. Morgenthaler, MD4Department of Pharmacy, Mayo Clinic, Rochester, MNRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MNRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MNRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN; Division of Health Care Policy and Research, Mayo Clinic, Rochester, MNDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN; Correspondence: Address to Timothy I. Morgenthaler, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905Objective: To study the impact of multiphase quality improvement efforts to enhance appropriate use of chemical and mechanical venous thromboembolism (VTE) prophylaxis (VTEP) on the rate of hospital-acquired VTE and determine whether efforts have been associated with increased bleeding complications. Patients and Methods: All adult inpatients discharged between January 1, 2005, and December 31, 2015, were included in the study. Retrospective interrupted time series analysis compared VTEP performance, VTE outcomes, and unintended consequences (derived from linked administrative and clinical data) across 5 improvement phases: baseline (January 1, 2005-December 31, 2006), paper order set phase (January 1, 2007-February 9, 2009), electronic order set phase (February 10, 2009-December 16, 2009), active reminder phase (December 17, 2009-May 31, 2012), and maintenance phase (June 1, 2012-September 30, 2015). Results: Guideline VTEP plan adherence at the end of the study period (including documenting contraindications) reached 88.8% (654,138 of 736,384 patient days). Delivery of pharmacological VTEP increased from 43.9% (49,155 of 111,906 patients) to 60.8% (75,784 of 124,676 patients); delivery of mechanical or pharmacological VTEP increased less (65.0% [431,791 of 664,087 patient days] to 67.4% [496,625 of 736,384 patient days]). Mean VTE rates decreased from 4.6 per 1000 hospitalizations (21.7 VTEs per month) at baseline to 4.3 per 1000 hospitalizations (18.0 VTEs per month) during the maintenance phase (P<.001). More than 97% of patients who had development of VTE (534 of 548) received VTEP, but 65.7% (360 of 548) experienced gaps of 1 or more days in VTEP delivery. Measured in-hospital bleeding rates were fairly consistent over the study (4.6% [5,198 of 111,906 patients] at baseline to 5.3% [6,662 of 124,676 patients] during the reminder phase). There was little change in rates of 7-day readmission with bleeding or VTE. Conclusion: Our VTEP project improved guideline compliance, increased the proportion of patients receiving VTEP, and was associated with a decrease in VTE. Gaps in VTEP delivery occurred despite protocoled order sets and electronic feedback. Further improvements in VTE may require new approaches.http://www.sciencedirect.com/science/article/pii/S2542454819301560 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jenna K. Lovely, PharmD, RPh, BCPS Joel A. Hickman, BS Matthew G. Johnson, MPH James M. Naessens, ScD, MPH Timothy I. Morgenthaler, MD |
spellingShingle |
Jenna K. Lovely, PharmD, RPh, BCPS Joel A. Hickman, BS Matthew G. Johnson, MPH James M. Naessens, ScD, MPH Timothy I. Morgenthaler, MD Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
author_facet |
Jenna K. Lovely, PharmD, RPh, BCPS Joel A. Hickman, BS Matthew G. Johnson, MPH James M. Naessens, ScD, MPH Timothy I. Morgenthaler, MD |
author_sort |
Jenna K. Lovely, PharmD, RPh, BCPS |
title |
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis |
title_short |
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis |
title_full |
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis |
title_fullStr |
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis |
title_full_unstemmed |
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis |
title_sort |
impact of a program to improve venous thromboembolism prophylaxis on incidence of thromboembolism and bleeding rates in hospitalized patients during implementation of programs to improve venous thromboembolism prophylaxis |
publisher |
Elsevier |
series |
Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
issn |
2542-4548 |
publishDate |
2020-04-01 |
description |
Objective: To study the impact of multiphase quality improvement efforts to enhance appropriate use of chemical and mechanical venous thromboembolism (VTE) prophylaxis (VTEP) on the rate of hospital-acquired VTE and determine whether efforts have been associated with increased bleeding complications. Patients and Methods: All adult inpatients discharged between January 1, 2005, and December 31, 2015, were included in the study. Retrospective interrupted time series analysis compared VTEP performance, VTE outcomes, and unintended consequences (derived from linked administrative and clinical data) across 5 improvement phases: baseline (January 1, 2005-December 31, 2006), paper order set phase (January 1, 2007-February 9, 2009), electronic order set phase (February 10, 2009-December 16, 2009), active reminder phase (December 17, 2009-May 31, 2012), and maintenance phase (June 1, 2012-September 30, 2015). Results: Guideline VTEP plan adherence at the end of the study period (including documenting contraindications) reached 88.8% (654,138 of 736,384 patient days). Delivery of pharmacological VTEP increased from 43.9% (49,155 of 111,906 patients) to 60.8% (75,784 of 124,676 patients); delivery of mechanical or pharmacological VTEP increased less (65.0% [431,791 of 664,087 patient days] to 67.4% [496,625 of 736,384 patient days]). Mean VTE rates decreased from 4.6 per 1000 hospitalizations (21.7 VTEs per month) at baseline to 4.3 per 1000 hospitalizations (18.0 VTEs per month) during the maintenance phase (P<.001). More than 97% of patients who had development of VTE (534 of 548) received VTEP, but 65.7% (360 of 548) experienced gaps of 1 or more days in VTEP delivery. Measured in-hospital bleeding rates were fairly consistent over the study (4.6% [5,198 of 111,906 patients] at baseline to 5.3% [6,662 of 124,676 patients] during the reminder phase). There was little change in rates of 7-day readmission with bleeding or VTE. Conclusion: Our VTEP project improved guideline compliance, increased the proportion of patients receiving VTEP, and was associated with a decrease in VTE. Gaps in VTEP delivery occurred despite protocoled order sets and electronic feedback. Further improvements in VTE may require new approaches. |
url |
http://www.sciencedirect.com/science/article/pii/S2542454819301560 |
work_keys_str_mv |
AT jennaklovelypharmdrphbcps impactofaprogramtoimprovevenousthromboembolismprophylaxisonincidenceofthromboembolismandbleedingratesinhospitalizedpatientsduringimplementationofprogramstoimprovevenousthromboembolismprophylaxis AT joelahickmanbs impactofaprogramtoimprovevenousthromboembolismprophylaxisonincidenceofthromboembolismandbleedingratesinhospitalizedpatientsduringimplementationofprogramstoimprovevenousthromboembolismprophylaxis AT matthewgjohnsonmph impactofaprogramtoimprovevenousthromboembolismprophylaxisonincidenceofthromboembolismandbleedingratesinhospitalizedpatientsduringimplementationofprogramstoimprovevenousthromboembolismprophylaxis AT jamesmnaessensscdmph impactofaprogramtoimprovevenousthromboembolismprophylaxisonincidenceofthromboembolismandbleedingratesinhospitalizedpatientsduringimplementationofprogramstoimprovevenousthromboembolismprophylaxis AT timothyimorgenthalermd impactofaprogramtoimprovevenousthromboembolismprophylaxisonincidenceofthromboembolismandbleedingratesinhospitalizedpatientsduringimplementationofprogramstoimprovevenousthromboembolismprophylaxis |
_version_ |
1724599092339802112 |